Nu-Med Plus (NUMD) insider logs new stock transaction
Nu-Med Plus (NUMD) insider Fred Tejada, SVP and Chief Geologist, logged a net buy of 17,381,250 shares. The transaction included grants of preferred stock and common stock, with holdings now totaling 129,782 Series A Preferred shares and 1,000,000 Series X Super Voting Preferred shares. The deal involves a voting agreement with other affiliated stockholders.
How this was made
The 30-second read
Why it matters
The filing provides fresh data on insider holdings, which can influence short‑term trading decisions.
Market read
First‑report insider purchase may affect NUMD's stock price and investor sentiment.
What to watch
Potential dilution from pending share exchanges or conversion of preferred stock.
Background
Nu‑Med Plus filed a Form 4 with the SEC reporting insider purchases and grants of preferred stock.
Ticker impact
Form 4 filing shows insider TEJADA FRED bought 16,381,250 common shares, indicating strong insider confidence.
Potential short-term upside as market absorbs insider buying.
Buy of >16M shares by SVP suggests confidence, but lack of price/valuation context limits certainty.
Market effects
Insider activity may draw attention to the mining sector where Nu‑Med operates.
Limited to US micro‑cap investors.
Minimal global impact.
Counterpoint
Insider buying could be a pre‑emptive move before a negative catalyst not yet disclosed.
Key entities
- InsiderTejada Fred
SVP and Chief Geologist of Nu‑Med Plus.
